PharmaCorp Rx Inc
XTSX:PCRX
PharmaCorp Rx Inc
XTSX:PCRX
Price:
0.425
CAD
-5.56%
Market Closed
Market Cap:
CA$74m
Income Statement
Earnings Waterfall
PharmaCorp Rx Inc
PharmaCorp Rx Inc
Income Statement
PharmaCorp Rx Inc
PharmaCorp Rx Inc
Currency: CAD
| Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Interest Expense |
0
|
0
|
0
|
|
| Revenue |
10
N/A
|
14
+42%
|
18
+27%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(6)
|
(8)
|
(11)
|
|
| Gross Profit |
4
N/A
|
5
+43%
|
7
+28%
|
|
| Operating Income | ||||
| Operating Expenses |
(5)
|
(6)
|
(7)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(6)
|
|
| Depreciation & Amortization |
(0)
|
(1)
|
(1)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
|
| Operating Income |
(1)
N/A
|
(1)
+37%
|
(0)
+72%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(0)
+72%
|
0
N/A
|
|
| Net Income | ||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(1)
|
(0)
|
0
|
|
| Income to Minority Interest |
0
|
0
|
0
|
|
| Net Income (Common) |
(1)
N/A
|
(0)
+53%
|
0
N/A
|
|
| EPS (Diluted) |
-0.01
N/A
|
0
N/A
|
0
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
